Invus Financial Advisors, LLC
- SEC CIK
- 0001802978
- Latest filing
- Aug 14, 2024
Holdings in Q4 2023
Holdings as of Dec 31, 2023, filed Feb 14, 2024. Long positions only; changes compare share counts with Q3 2023.
- Positions
- 7
- −1 vs. Q3 2023
- Portfolio value
- $127.8M
- −$31.8M (−19.9%) vs. Q3 2023
| Security | Class | Shares | Value | % of portfolio | Share change | Action | History |
|---|---|---|---|---|---|---|---|
| TBLATaboola.com Ltd. | ORD SHS | 9,969,495 | $43.2M | 33.8% | 00.0% | Unchanged | History |
| RCUSArcus Biosciences, Inc. | COM | 1,612,077 | $30.8M | 24.1% | 00.0% | Unchanged | History |
| CPNGCoupang, Inc. | CL A | 1,375,947 | $22.3M | 17.4% | −260,000−15.9% | Reduced | History |
| IHSIHS Holding Ltd | ORD SHS | 2,357,520 | $10.8M | 8.5% | +1,395,367+145.0% | Added | History |
| ORICOric Pharmaceuticals, Inc. | COM | 1,007,575 | $9.27M | 7.3% | 00.0% | Unchanged | History |
| IONQIonQ, Inc. | COM | 500,000 | $6.20M | 4.8% | 00.0% | Unchanged | History |
| NVCRNovoCure Ltd | ORD SHS | 350,884 | $5.24M | 4.1% | 00.0% | Unchanged | History |
Sold out since Q3 2023 (1)
Positions held at the end of Q3 2023 that are gone from this filing.